Speaker illustration

Doctor Oliver Cohen

National Amyloidosis Centre, Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)

Global longitudinal strain predicts survival and response in patients with systemic AL amyloidosis. analysis of 915 patients from the ALchemy prospective trial

Event: ESC Congress 2020

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Blockbusters from the Young in Heart Failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb